- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT00332514
Post-Discharge Follow-Up Phone Call by a Pharmacist and Impact on Patient Care
The purpose is to analyze whether a follow-up telephone call by a pharmacist after patient discharge from the hospital can improve patient outcomes.
Patients will be interviewed via telephone within 72 hours of being discharged home from the hospital. Patients will be questioned on three main topics. They are:
- Medical care
- Medications
- Follow-up appointments
The purpose is to find out if people understand discharge medications, have obtained those medications, are having any problems with their medications and have scheduled necessary follow-up appointments. It will be determined if a telephone call by a pharmacist will prevent patients from needing to go to the Emergency Room or being admitted back to the hospital.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
There is a time between hospital discharge and patient follow-up that has been deemed by many healthcare workers as a "black hole " (1). It is a time during which continuity of care is of utmost importance, yet there is no effective uniform system in place to ensure this vital continuity. During the post-discharge period (time from when the patient leaves the hospital to the time of first follow-up appointment), new medical problems can arise and old ones can be exacerbated. Additionally, patients can encounter innumerable barriers to healthcare, including difficulty obtaining medications and securing appointments with physicians or specialists. Also, patients may not have received proper counseling on new discharge medications, including proper use and potential side effects. Despite this important aspect of patient care, only a paucity of literature on the topic exists. Of the literature that does exist, it suggests that patient education concerning discharge planning and the post-discharge period is an aspect of care that is in great need of improvement and an excellent opportunity for intervention by a pharmacist.
This led to our research hypothesis, can a follow-up phone call from a pharmacist improve patient outcomes?
The primary endpoint of this study is a reduction in the number of hospital readmissions (any cause) during the 30-day post-discharge period. Thirty-day readmission rates will be compared to see if there is a difference between the intervention group (follow-up phone call) and control group (no phone call). The secondary outcomes include the number of patients in the study group for whom medication errors, complications or misuse could be identified.
References: (1). Kathuria, et al. Post-discharge follow-up: hospitalists dial into the "black hole". Hospitalist and Inpatient Management Report, June 2003
Type d'étude
Inscription
Phase
- Phase 2
Contacts et emplacements
Lieux d'étude
-
-
Massachusetts
-
Boston, Massachusetts, États-Unis, 02118
- Boston Medical Center
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- admission to Internal Medicine Service on the Menino Pavilion, either Firm A or B at Boston Medical Center located in Boston, MA
- age greater than or equal to 18 years
- discharge to home from the inpatient General Medical Service
- English-speaking or lives with English-speaking person
- access to a working phone
Exclusion Criteria:
- admission to any other service at Boston Medical Center located in Boston, MA besides Internal Medicine Firms A or B
- age less than 18 years
- discharge to site other than home
- non-English-speaking or does not live with an English-speaking person
- no access to a working phone
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Non randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Autre: Patients offered follow-up phone call
Patients offered follow-up telephone call
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
---|
The primary endpoint of this study is a reduction in the number of hospital readmissions (any cause) during the 30-day post-discharge period.
|
Mesures de résultats secondaires
Mesure des résultats |
---|
The secondary outcomes include the number of patients in the study group for whom medication errors, complications or misuse could be identified.
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Gail M Burniske, PharmD, BCPS, Boston Medical Center
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- H-23071
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Réadmission, Hôpital
-
Weill Medical College of Cornell UniversityComplétéPatients hospitalisés modérément malades au campus Cornell du New York-Presbyterian HospitalÉtats-Unis
Essais cliniques sur telephone call by a pharmacist
-
Instituto de Investigación Hospital Universitario...Recrutement